Skip to main content
OpenTrials

Clinical trial condition

Hepatitis B, Chronic

Explore clinical trials studying Hepatitis B, Chronic. Study availability and eligibility vary by location and protocol.

162 public trials 11 recruiting studies
Refine in advanced search Browse all conditions

Hepatitis B, Chronic trial results

Not Yet Recruiting

Study of AHB-137 in Chronic Hepatitis B (CHB) Participants in North America and Europe Regions

NCT07654283

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • Stanford University Palo Alto, California, United States
  • University of Maryland Baltimore, Maryland, United States
  • NYU Langone Health New York, United States
  • Texas Liver Institute San Antonio, Texas, United States
View Trial Details
Not Yet Recruiting

A Clinical Study to Evaluate the Efficacy of TQA3038 Injection in Patients With Chronic Hepatitis B

NCT06452693

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • The First Affiliated Hospital of Bengbu Medical College Bengbu, Anhui, China
  • Mengchao Hepatobiliary Hospital of Fujian Medical University Fuzhou, Fujian, China
  • Gansu province people hospital Lanzhou, Gansu, China
  • The Third Affiliated Hospital of Sun Yat sen University Guangzhou, Guangdong, China
View all 22 locations
View Trial Details
Completed

Study to Investigate the Safety and Efficacy of BRII-835 and BRII-179 Combination Therapy Treating Chronic Hepatitis B Virus (HBV) Infection

NCT04749368

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • Investigative Site 61002 Kingswood, New South Wales, Australia
  • Investigative Site 61001 Westmead, New South Wales, Australia
  • Investigative Site 61004 Herston, Queensland, Australia
  • Investigative Site 88602 Changhua, Taiwan, China
View all 28 locations
View Trial Details
Completed

Study of Bepirovirsen in Nucleos(t)Ide Analogue-treated Participants With Chronic Hepatitis B (B-Well 2)

NCT05630820

Conditions
Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +15 more
Locations
  • GSK Investigational Site Centreville, Alabama, United States
  • GSK Investigational Site Los Angeles, California, United States
  • GSK Investigational Site San Francisco, California, United States
  • GSK Investigational Site San Francisco, California, United States
View all 171 locations
View Trial Details

Related conditions